Small Cell Lung Cancer Treatments - Strengthen Your Immune System to Fight Against Cancer!
MGN-3 is an immune system stimulant and it is extremely effective in strengthening the Natural Killer (NK) cells. The Natural Killer cells are one of the first lines of defences against viral and bacterial infections, as well as cancer. The stronger these cells the more effectively they will fight against cancer.
It is proven that people who have low NK cells activity, are more likely to experience cancer and various other diseases. What matters is the activity of NK cells, not the number of these cells. MGN-3 has also shown to increase the level of activity amongst other immune system cells, such as T cells and B cells. It can also increase the production of several cytokines, like tumor necrotic factor-alpha, interferon gamma, nterleukin-12 and Interleukin-2.
Dr. Ghoneum, who is an internationally recognized expert in the field of cancer immune therapy - which is a therapy that uses biological response modifiers or BRM-s, to activate Natural Kill cells in the body and kill cancer cells in the body, stated that MGN-3 proved to be superior to other small cell lung cancer treatments, not only because of its lack of toxicity, but also because it provides a boost to the immune system over a long period. He also said that other BRM-s effectiveness diminished over time, even if the patient was still taking them.
This is just one example of the possible small cell lung cancer treatments. The main thing is to be active and research for various alternative treatments and natural cures, that can help you. If you lose all hope and give up, then you have very little chance to beat cancer. It is also important find a doctor, that you can discuss these kinds of treatments, the patient and the doctor have to work together. There are so many examples of people, who successfully beat cancer, so never give up hope.
Article Source: http://EzineArticles.com/?expert=Jaan_Tamm
---------------------------------
Alternative Cancer Treatments For Stage IV Cancer Patients
